Diageo advances under new CEO with cost control, brand-building, H2 improvement from Guinness, RTD innovation, and future ...
Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going. The Orbital Therapeutics deal is Bristol’s largest since February 2024. Earnings, Fed Rates Mean Stocks Can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback